中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2015年
13期
87-88
,共2页
曲安奈德%利多卡因%甲钴胺%封闭治疗%骨科疼痛%疗效%护理
麯安奈德%利多卡因%甲鈷胺%封閉治療%骨科疼痛%療效%護理
곡안내덕%리다잡인%갑고알%봉폐치료%골과동통%료효%호리
triamcinolone acetonide%lidocaine%mecobalamin%block therapy%orthopedic pain%curative efficacy%nursing
目的：观察曲安奈德、利多卡因及甲钴胺封闭治疗骨科急慢性疼痛的疗效，并分析治疗过程中的护理要点。方法将184例患者随机分为对照组和观察组，各92例。对照组患者采用利多卡因及曲安奈德封闭治疗，观察组患者加用甲钴胺，疗程均为14 d。结果与治疗前比较，两组急性疼痛患者治疗后视觉模拟评分（VAS）均明显下降（ P﹤0.05），但组间差异不明显；两组慢性疼痛患者间治疗后VAS均明显下降（ P﹤0.05），观察组下降更明显（ P﹤0.05）。对照组和观察组患者治疗总有效率分别为61.92％和73.91％（ P﹤0.05）。两组患者治疗过程中均未见明显不良反应发生。结论曲安奈德、利多卡因及甲钴胺封闭治疗骨科急慢性疼痛安全、有效，能有效改善患者疼痛症状，值得临床推广。
目的：觀察麯安奈德、利多卡因及甲鈷胺封閉治療骨科急慢性疼痛的療效，併分析治療過程中的護理要點。方法將184例患者隨機分為對照組和觀察組，各92例。對照組患者採用利多卡因及麯安奈德封閉治療，觀察組患者加用甲鈷胺，療程均為14 d。結果與治療前比較，兩組急性疼痛患者治療後視覺模擬評分（VAS）均明顯下降（ P﹤0.05），但組間差異不明顯；兩組慢性疼痛患者間治療後VAS均明顯下降（ P﹤0.05），觀察組下降更明顯（ P﹤0.05）。對照組和觀察組患者治療總有效率分彆為61.92％和73.91％（ P﹤0.05）。兩組患者治療過程中均未見明顯不良反應髮生。結論麯安奈德、利多卡因及甲鈷胺封閉治療骨科急慢性疼痛安全、有效，能有效改善患者疼痛癥狀，值得臨床推廣。
목적：관찰곡안내덕、리다잡인급갑고알봉폐치료골과급만성동통적료효，병분석치료과정중적호리요점。방법장184례환자수궤분위대조조화관찰조，각92례。대조조환자채용리다잡인급곡안내덕봉폐치료，관찰조환자가용갑고알，료정균위14 d。결과여치료전비교，량조급성동통환자치료후시각모의평분（VAS）균명현하강（ P﹤0.05），단조간차이불명현；량조만성동통환자간치료후VAS균명현하강（ P﹤0.05），관찰조하강경명현（ P﹤0.05）。대조조화관찰조환자치료총유효솔분별위61.92％화73.91％（ P﹤0.05）。량조환자치료과정중균미견명현불량반응발생。결론곡안내덕、리다잡인급갑고알봉폐치료골과급만성동통안전、유효，능유효개선환자동통증상，치득림상추엄。
Objective To observe the efficacy of block therapy of triamcinolone acetonide, lidocaine and mecobalamin in orthopedic acute and chronic pain and its nursing key points. Methods 184 orthopedic patients with acute and chronic pain were randomly divided into 2 groups, 92 cases in each group. The control group adopted the block therapy of lidocaine and triamcinolone acetonide, while the obser-vation groups was added with mecobalamin on the basis of the control group treatment. The course of treatment was 14 d for both two groups. Results The pain VAS scores before treatment had no statistically significant difference between the acute pain patients in the two groups, while which after treatment in the two groups had statistically significant difference compared with before treatment ( P ﹤0. 05 ) , but the pain VAS scores after treatment had no significant difference between the two groups. In addition, the VAS score before treatment had no significant difference between the chronic pain patients in the two groups, whereas which after treatment in the two groups had significant difference compared with before treatment ( P ﹤ 0. 05 ) , in which the VAS score in the observation group was sig-nificantly lower than that in the control group, the difference was statistically significant ( P ﹤ 0. 05 ) . The total effective rates in the control group and the observation group were 61. 92% and 73. 91% respectively, the difference was statistically significant ( P ﹤ 0. 05 ) . No obvious adverse reactions during treatment were found in the two groups. Conclusion The block therapy of triamcinolone acetonide, lidocaine and mecobalamin in treating orthopedic acute and chronic pain is safe and effective, can effectively improve the pain symptoms of patients and deserves to be clinically popularized.
